159025-89-5 Usage
Description
(R,S)-2-N-Boc-3-Phenylpropyl cyanide is a chemical compound with the formula C16H21NO2 and a molecular weight of 259.34 g/mol. It is a cyanide derivative featuring a Boc-protecting group and a phenylpropyl side chain, making it a chiral compound with a pair of enantiomers, (R)and (S)-2-N-Boc-3-Phenylpropyl cyanide, each exhibiting different optical activities. This versatile compound is known for its reactivity and structural features, which contribute to its wide range of applications in organic synthesis.
Uses
Used in Pharmaceutical Industry:
(R,S)-2-N-Boc-3-Phenylpropyl cyanide is used as an intermediate in organic synthesis for the production of various drugs and pharmaceuticals. Its unique structural features and reactivity make it a valuable component in the development of complex organic molecules, which are essential for creating new and improved medications.
Used in Organic Synthesis:
(R,S)-2-N-Boc-3-Phenylpropyl cyanide is used as a key building block in the synthesis of a wide range of complex organic molecules. Its Boc-protecting group and phenylpropyl side chain provide a foundation for further chemical reactions, allowing for the creation of diverse and intricate molecular structures.
Check Digit Verification of cas no
The CAS Registry Mumber 159025-89-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,0,2 and 5 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 159025-89:
(8*1)+(7*5)+(6*9)+(5*0)+(4*2)+(3*5)+(2*8)+(1*9)=145
145 % 10 = 5
So 159025-89-5 is a valid CAS Registry Number.
159025-89-5Relevant articles and documents
Novel compounds that inhibit dipeptidyl peptidase (DPP-IV) and neprilysin (NEP) and/or angiotensin converting enzyme (ACE)
-
Page/Page column 12, (2010/10/20)
This invention relates to novel compounds, compositions containing the compounds, that inhibit dipeptidyl peptidase (especially DPP-IV) and neprilysin (NEP, neutral endopeptidase) as well as dipeptidyl peptidase (especially DPP-IV) and angiotensin converting enzyme (ACE) and/or dipeptidyl Peptidase (especially DPP-IV) and vasopeptidases (especially ACE and NEP). These compounds and pharmaceutical compositions thereof are useful for the treatment as well as the prevention of type 2 diabetes mellitus.
